Nitric oxide has been suggested to be involved in the regulation of bone turnover, especially in pathological conditions characterized by release of bone-resorbing cytokines. The cytokine IL-1 is thought to act as a mediator of periarticular bone loss and tissue damage in inflammatory diseases such as rheumatoid arthritis. IL-1 is a potent stimulator of both osteoclastic bone resorption and expression of inducible nitric oxide synthase (iNOS) in bone cells and other cell types. In this study, we investigated the role that the iNOS pathway plays in mediating the bone-resorbing effects of IL-1 by studying mice with targeted disruption of the iNOS gene. Studies in vitro and in vivo showed that iNOS-deficient mice exhibited profound defects of IL-1-induced osteoclastic bone resorption but responded normally to calciotropic hormones such as 1,25 dihydroxyvitamin D3 and parathyroid hormone. Immunohistochemical studies and electrophoretic mobility shift assays performed on bone marrow cocultures from iNOS-deficient mice showed abnormalities in IL-1-induced nuclear translocation of the p65 component of NFB and in NFB-DNA binding, which were reversed by treatment with the NO donor S-nitroso-acetyl penicillamine. These results show that the iNOS pathway is essential for IL-1-induced bone resorption and suggest that the effects of NO may be mediated by modulating IL-1-induced nuclear activation of NFB in osteoclast precursors.
I
L-1 is a pleiotropic cytokine (1) that has potent stimulatory effects on nitric oxide production (2) and bone remodeling (3) (4) (5) . On binding to its receptor, IL-1 initiates a signaling cascade that culminates in activation of NFB (6) . The importance of this system in normal bone physiology is demonstrated by the fact that transgenic mice that are deficient in the IL-1 receptor are resistant to ovariectomy-induced bone loss (7) and that deficiency of other components of the pathway, such as TRAF6 (8) and the p50͞p52 subunits of NFB (9) , leads to osteopetrosis because of failure of osteoclast differentiation. Its importance in the pathogenesis of pathological bone loss is similarly illustrated by the fact that treatment with IL-1 receptor antagonist slows bone erosions in patients with rheumatoid arthritis (10) and that IL-1 inhibitors block the osteoclastactivating activity of bone marrow (BM) cells derived from multiple myeloma patients (11) .
Inflammatory conditions such as rheumatoid arthritis, which are characterized by local osteolysis, are associated with activation of inducible nitric oxide synthase (iNOS) (12) (13) (14) . This fact has led to the suggestion that NO derived from the iNOS pathway may act as a mediator of cytokine-induced effects on bone turnover (15) (16) (17) (18) . Studies with NOS inhibitors and NO donors have indicated that high concentrations of NO inhibit osteoclastic bone resorption in vitro (15, 19, 20) , whereas lower concentrations may be essential for normal osteoclast activity (21) and, in some circumstances, may enhance IL-1-induced bone resorption (16) . This finding suggests that NO may play a role in mediating some effects of cytokines on bone resorption, but the studies performed so far have been unable to assess the relative importance of NO in relation to other mediators of cytokine action or to determine which isoform is responsible. Finally, it remains possible that some of the responses observed that have been attributed to NO could instead have been mediated by nonspecific inhibition of other metabolic pathways by NOS inhibitors (22) . To resolve these issues and to clarify the role that NO derived from the iNOS pathway plays in cytokineinduced bone resorption, we studied the effects of IL-1 on osteoclast formation and bone resorption in transgenic mice with targeted inactivation of the iNOS gene.
Methods
Generation of iNOS-Deficient Mice. The murine iNOS gene was disrupted by introducing a targeted mutation into embryonic stem cells derived from the 129 mouse strain as described (23) . The homozygous, heterozygous, and wild-type mice thus generated were backcrossed onto MF1 mice for three generations to generate a colony on a mixed 129 ϫ MF1 background. The phenotype of these mice has previously been extensively characterized (24, 25) , and Western blotting has shown that peritoneal macrophages from these mice do not produce iNOS after cytokine stimulation (26) . Low levels of nitrite have been detected in peritoneal macrophages stimulated for up to 72 h with bacterial lipopolysaccharide and IFN-␥, however, which seems to be attributable to either cytokine-induced activation or induction of constitutive NOS isoforms (26) . A second colony was established in a similar way onto a pure 129 background. Some of the in vitro studies were performed with cells from both strains of mice with similar results (data not shown), whereas all of the in vivo studies were performed on littermates derived from the 129 ϫ MF1 colony, which have an identical genetic background.
Osteoblast-BM Cocultures. Osteoclast formation was studied by using an adaptation of the BM-osteoblast coculture system (27) as previously described (20) . Cocultures of osteoblasts and BM cells were performed in 48-well or 96-well tissue culture plates. In 96-well plates, the osteoblasts and BM cells were plated at 10 4 cells per well and 2 ϫ 10 1,25-dihydroxyvitamin D 3 . Double the amount of cells and culture medium was used in 48-well cultures. Reagents used in stimulation of the cultures were human recombinant IL-1␤ (specific activity 5 ϫ 10 7 units͞ml; Boehringer Mannheim), human parathyroid hormone 1-84 (PTH; Sigma); S-nitrosoacetyl pencillamine (SNAP; Alexis Pharmaceuticals, Nottingham, U.K.), and L-n-monomethylarginine (Sigma). The cultures were terminated after 9 days and fixed with 4% buffered formalin͞saline (pH 7.4). Osteoclasts were identified by tartrateresistant acid phosphatase staining and resorption pits by reflected light microscopy as described (20) .
Immunostaining for NFB. The effects of IL-1␤ on nuclear translocation of NFB were studied in osteoblast-BM cocultures treated with IL-1␤ or vehicle at day 4. The cultures were fixed with 50% acetone in PBS for 10 min and washed twice in PBS. The cells then were incubated for 30 min with an antibody directed against the p65 subunit of NFB (Santa Cruz Biotechnology), washed three times in PBS, incubated for 30 min with biotinylated rabbit anti-goat antibody, washed three times in PBS, and incubated with horseradish peroxidase-conjugated ABC complex (Vectastain ABC HRP elite; Vector Laboratories). After a further three washes, staining was detected by diaminobenzidine according to the manufacturer's instructions (Vector Laboratories). Cells were scored as positive or negative by an observer who was blinded with regard to the experimental details. Four fields at ϫ20 magnification were scored per well. The identity of the BM cells in these cultures was determined by their typical morphology and confirmed by staining for the pan-leukocyte marker CD45 with an anti-CD45 polyclonal antibody (Sigma). The identity of osteoblasts was assessed morphologically and confirmed by histochemical staining for alkaline phosphatase by using fast red as the substrate as described (28) . ) were cultured for 5 days in a 9-cm Petri dish in 10 ml of ␣MEM supplemented with 10% FCS, antibiotics, and 10 nM 1,25-dihydroxyvitamin D 3 before stimulation. EMSA were performed on nuclear protein extracts prepared from these cocultures as described (29) , by using double-stranded oligonucleotides (Promega) containing a NFB consensus sequence (underlined), ATGTGAGGGACTTTC-CCAGGC, end-labeled with ␥-32 P by using T4 polynucleotide kinase (Amersham Pharmacia). Unlabeled oligonucleotides of the same sequence were used in 100-fold excess in the competition experiments. EMSA assays were imaged and quantitated with a Bio-Rad Personal FX molecular imager and QUANTITY ONE software.
NO Production. NO production was assessed by measuring the stable end product of NO, nitrite, in culture medium by using the Griess reaction as described previously (17) .
In Vivo Experiments. We studied the effects of IL-1 on bone resorption in wild-type and iNOS-deficient mice in vivo by using an adaptation of the method described by Boyce et al. (5) . Four-day-old mice were injected three times a day over the calvarial bones with 10 l of recombinant murine IL-1␣ (5 mg͞ml; Calbiochem) or vehicle (saline) on 3 consecutive days. The mice were killed 4 days after the last injection, and the calvarial bones were fixed in 4% buffered formalin͞saline (pH 7.4). Undecalcified calvarial bones were embedded in glycolmethacrylate, and 3-m sections were prepared on a microtome (Jung, Heidelberg, Germany). Sections were stained with von Kossa reagent, and histochemical staining was performed for tartrate-resistant acid phosphatase, followed by counterstaining with light green. Histomorphometric analysis was performed according to standard nomenclature (30), using a Leitz Q500 MC image analysis system.
Statistics.
Results were analyzed by using analysis of variance, followed by Dunnet's post test with SPSS for Windows, unless otherwise stated.
Results

iNOS-Knockout (KO) Mice Show Defects in IL-1-Induced Osteoclast
Formation and Bone Resorption in Vitro. IL-1␤ (10 units͞ml) failed to stimulate osteoclast formation (Fig. 1a) or bone resorption (Fig. 1b ) in cocultures prepared with osteoblasts and BM cells from iNOS-deficient mice. This failure appeared to be caused by a deficiency of osteoblast-derived NO, because the response to IL-1␤ was normal in cocultures of wild-type (WT) osteoblasts and iNOS KO BM cells but was defective when WT BM cells were cultured with KO osteoblasts (Fig. 1 a and b) . The amount of NO produced by cocultures of WT osteoblasts and KO BM was similar to that in WT͞WT cocultures and was significantly greater than that produced by cocultures where the BM cells were derived from WT and osteoblasts from KO animals (Fig.  1c) , indicating that osteoblasts are the main source of NO in this system. Expression of the bone resorption data in terms of the area of resorption produced per osteoclast showed no significant difference between the groups, indicating that the main effect of IL-1 was on osteoclast formation rather than on osteoclast activity (Fig. 1d) . The pharmacological NO donor SNAP did not stimulate osteoclast formation or bone resorption when administered alone (data not shown), but reversed L-n-monomethylarginine-mediated inhibition of IL-1-induced bone resorption in WT cocultures (Fig. 2) . These data indicate that although NO is necessary for IL-1-induced bone resorption, it does not stimulate bone resorption in the absence of IL-1. The defective osteoclast formation and bone resorption observed in cocultures prepared from KO animals was relatively specific for IL-1 because osteoclasts formed normally in response to 1,25 dihydroxyvitamin D 3 ( Fig. 1 a and b, without IL-1) . Furthermore, stimulation of 1,25 dihydroxyvitamin D 3 -treated cultures with 40 nM PTH resulted in a Ϸ2.5-fold increase in osteoclast numbers and bone resorption as compared with controls in both WT and KO cultures (Table 1) .
iNOS-Deficient Mice Exhibit Defects in IL-1-Induced Bone Resorption in
Vivo. The effects of IL-1 on bone resorption in vivo were studied by injecting IL-1␣ over the calvarial bones of KO and WT control mice. There was no difference in the histological appearance of calvarial bones of WT and iNOS-deficient animals that had been injected with vehicle ( Fig. 3A and B) . Osteoclastic bone resorption clearly was increased in response to IL-1␣ injections in WT mice (Fig. 3C) but not in KO mice (Fig. 3D) . The defective response to IL-1␣ in KO mice was confirmed by quantitative histomorphometric analysis of the calvarial bones (Fig. 4) . These data showed a substantial increase in both osteoclast numbers and eroded surfaces in WT animals as compared with no increase in osteoclast numbers and only a marginal increase in eroded surfaces in KO mice.
BM Cells from iNOS-Deficient Mice Exhibit Abnormalities of IL-1-
Induced NFB Activation. To investigate the mechanisms responsible for the defect in osteoclast formation in KO mice, we studied the effects of IL-1 on nuclear translocation of NFB in BM cocultures from WT and KO mice by quantitative immunohistochemical staining (Fig. 5) . Nuclear staining for the p65 component of NFB was detected in 90% of BM cells and virtually 100% of osteoblast-like cells within 30 min of exposure to IL-1 (10 units͞ml) in cocultures from both WT and KO animals. Osteoblast nuclear staining for NFB-p65 disappeared rapidly in both WT and KO cultures and was absent 24 h after stimulation. In BM cells, however, nuclear staining for NFB persisted in about 90% of cells for up to 24 h. Nuclear staining was lost more rapidly from BM cells in KO cultures. By 6 h, less than 20% of cells were positive (P Ͻ 0.05 from WT), and by 24 h, Cocultures were performed on dentine as described. PTH (4 ϫ 10 Ϫ8 M) or vehicle was added on day 7, and the cultures were terminated on day 10.
Values are expressed as mean Ϯ SD. ** , P Ͻ 0.01; *** , P Ͻ 0.001; from vehicle; n ϭ 6. less than 2% were positive (P Ͻ 0.001 from WT). These abnormalities of NFB-p65 nuclear translocation in BM cells from iNOS-deficient animals were rescued by addition of the NO donor SNAP. Representative photomicrographs from control and IL-1-stimulated cultures are shown in Fig. 6 , which shows absence of nuclear staining for NFB-p65 under control conditions in BM cells or osteoblasts (Fig. 6A) . Within 30 min of exposure to IL-1, there was obvious nuclear staining of both osteoblasts (Fig. 6B , filled arrows) and BM cells (Fig. 6B , open arrows). After 24 h of IL-1 stimulation, most WT BM cells still showed nuclear staining (Fig. 6C) , whereas the nuclei of the iNOS KO BM cells were predominantly negative (Fig. 6D) . The phenotype of the BM cells and osteoblasts was confirmed by typical morphology and staining for the pan-leukocyte marker CD45 and the osteoblast marker alkaline phosphatase, respectively (data not shown). Further experiments were performed using EMSA to determine whether the differences in p65 nuclear translocation were accompanied by differences in NFB-DNA binding (Fig. 7) . Stimulation with IL-1 caused an increase in NFB-DNA binding in both WT and iNOS KO cocultures at 2 h. The band shift corresponding to the NFB-DNA complex still was clearly detectable after 24 h in the WT coculture, whereas NFB-DNA binding had returned to control levels in the iNOS KO cultures. Summated data from three experiments showed that the stimulation of NFB-DNA binding after 2 h was 1.87-fold in WT cultures as compared with 1.64-fold in iNOS KO. Corresponding figures for the 24 h time point were 1.77-fold for WT and 1.02-fold for iNOS KO (P Ͻ 0.01). Further studies showed that NO alone was capable of causing NFB activation because NFB-DNA binding was enhanced in both WT and iNOS cocultures by addition of the NO donor SNAP in the absence of IL-1.
Discussion
Previous studies have indicated that NO may play a role in mediating the effects of IL-1 on bone resorption in vitro (15, 16) , but they have been unable to assess its role in vivo, to determine the relative importance that NO plays in relation to other possible mediators of cytokine action, or to define which isoform is responsible. Finally, it remains possible that some of Mice from two different litters were used in each group. * , P Ͻ 0.05 from vehicle; ** , P Ͻ 0.01; *** , P Ͻ 0.001. WT saline, n ϭ 7; WT IL-1, n ϭ 8; iNOS KO saline, n ϭ 6; iNOS KO IL-1, n ϭ 7. the responses observed that previously have been attributed to NO could have been mediated by nonspecific effects of NOS inhibitors on other metabolic pathways (22) . The data presented here are important in that they demonstrate unequivocally that NO derived from the iNOS pathway plays an essential role in mediating the effects of IL-1 on osteoclast formation and bone resorption both in vitro and in vivo. BM cocultures prepared from mice with iNOS deficiency did not show the expected stimulation of osteoclast formation or bone resorption in vitro on stimulation with IL-1, and injections of IL-1 over the calvarial bones of iNOS-deficient mice similarly failed to stimulate bone resorption in vivo. Coculture studies demonstrated that the effects of IL-1 on osteoclast formation and bone resorption were crucially dependent on osteoblastderived NO. Thus, cocultures of WT osteoblasts and knockout BM cells responded to IL-1 normally, whereas the stimulatory effects of IL-1 on NO production were blunted and those effects on osteoclast formation and bone resorption were absent in cocultures of knockout osteoblasts and WT BM cells. These data indicate that osteoblasts are the main source of NO in the coculture system and that osteoblast-derived NO acts in a paracrine fashion on cells within the BM compartment to promote IL-1-induced osteoclast formation and bone resorption. It is of interest that the requirement for NO was relatively specific for IL-1-induced bone resorption; the NO donor SNAP did not stimulate osteoclast formation or bone resorption in the absence of IL-1, and osteoclasts formed normally in KO cultures stimulated with 1,25 dihydroxyvitamin D 3 and PTH. These findings are in broad agreement with our previous work, which has shown that NOS inhibitors suppress bone resorption induced by IL-1 and tumor necrosis factor and that the NO donor SNAP acts to enhance the bone resorptive effects of IL-1, but not PTH, in the mouse calvarial bone resorption assay (16) . Prostaglandins also have been suggested to act as mediators of IL-1-induced effects on bone resorption in rats (31) , and other workers have shown that cytokines, including IL-1, activate both the iNOS pathway and prostaglandin E 2 production in rat osteoblasts and that NO can itself activate prostaglandin E production (32) . Our data do not exclude a role for prostaglandins as mediators of IL-1-induced bone resorption, but rather indicate that NO plays a predominant role, at least under the experimental conditions described in this paper. This finding is in keeping with the work of previous investigators who found that the stimulatory effects of IL-1 on bone resorption in mice could not be blocked by indomethacin either in vitro (4) or in vivo (5) .
Although our studies demonstrate that NO derived from the iNOS pathway is essential for IL-1-induced bone resorption, the NO donor SNAP did not increase bone resorption in the absence of IL-1 stimulation. This result indicates that NO probably acts by enhancing or potentiating the effects of signaling pathways induced by IL-1 in bone cells to enhance osteoclast differentiation. We investigated this possibility by studying the effects of IL-1 on nuclear translocation of the p65 component of NFB and on NFB-DNA binding in BM cocultures from WT and iNOS-deficient mice. NFB was chosen for these studies because it is the terminal component of the IL-1 signaling cascade (33) and because previous work had shown that NFB is essential for osteoclast differentiation (9, 34) . Normally, NFB is held in an inactive state by the IB inhibitory proteins. When cells are exposed to stimuli that activate the NFB pathway, IB proteins become phosphorylated, inducing proteasome-mediated degradation of IB and allowing nuclear translocation of NFB (35, 36) . Quantitative immunohistochemical staining showed no differences in the kinetics of nuclear translocation of the p65 component of NFB in osteoblasts from WT and KO cultures. However, studies of BM cells in these cultures showed marked differences; nuclear staining of NFB-p65 was sustained for up to 24 h in 90% of cells from WT cultures, but only 20% of nuclei remained positive in knockout cultures at 6 h, and less than 2% were positive at 24 h. EMSA showed that these differences in p65 nuclear translocation were accompanied by markedly reduced NFB-DNA binding in the iNOS KO cultures after 24 h, which indicates that an intact iNOS pathway is required to sustain NFB activation in BM cells from which osteoclasts are derived. The abnormalities of nuclear translocation of NFB were restricted to cells in the BM compartment and could be reversed by the NO donor SNAP, which was able to directly stimulate NFB-DNA binding in the iNOS KO cocultures. These data are consistent with the findings of other workers who have shown that NO can stimulate NFB-DNA binding in T cells (37) , endothelial cells (38) , macrophages (39) , and neurons (40) . Because NFB plays an essential role in osteoclast differentiation (9, 34) , the rapid attenuation of IL-1-induced NFB nuclear translocation in BM cells would be predicted to impair osteoclast formation and bone resorption, as was observed in the present study. Recent work has shown that the receptor activator of NFB (RANK) ligand͞ osteoprotegerin pathway plays an essential role in osteoclast differentiation and activation (41) (42) (43) , and that many boneresorbing factors, including IL-1, up-regulate expression of RANK ligand in osteoblasts, suggesting that these substances may regulate osteoclast differentiation and activity by modulating the RANK ligand͞RANK pathway (44) . Major defects of this pathway in iNOS-deficient mice can be excluded by the fact that 1,25 dihydroxyvitamin D 3 and PTH stimulated osteoclast formation and bone resorption normally. Further work is necessary to determine whether the defects of IL-1-induced bone resorption and NFB activation that we observed in iNOS-deficient mice are mediated by direct effects on the NFB pathway or by changes in expression of RANK ligand, osteoprotegerin, RANK, and other components of the RANK signaling pathway.
In conclusion, the results presented in this paper indicate that the iNOS pathway plays an essential role in mediating the effects of IL-1 on bone resorption by an NFB-dependent mechanism. These findings suggest that pharmacological inhibitors of this pathway could be of value in preventing bone loss in diseases associated with cytokine activation, such as rheumatoid arthritis.
